Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-R-3986 | OPC-28326 CAS No.167626-17-7 | OPC-28326/CAS No.167626-17-7 is a selective peripheral vasodilator and an angatonist of α2-adrenergic receptor, with Ki of 2040, 285, and 55 nM for α2A-, α2B- and α2C-adrenoceptors, respectively. | price> |
| R-R-3987 | Esmolol-d7 hydrochloride CAS No.1346598-13-7 | Esmolol-d7 (hydrochloride)/CAS No.1346598-13-7 is the deuterium labeled Esmolol hydrochloride. Esmolol hydrochloride is a beta adrenergic receptor blocker. | price> |
| R-R-3988 | Dronedarone-d6 hydrochloride CAS No.1329809-23-5 | Dronedarone-d6 (hydrochloride)/CAS No.1329809-23-5 is the deuterium labeled Dronedarone. Dronedarone hydrochloride, a derivative of Amiodarone (HY-14187), is a class III antiarrhythmic agent for the study of atrial fibrillation (AF) and atrial flutter. Dronedarone hydrochloride is a potent blocker of multiple ion currents, including potassium current, sodium current, and L-type calcium current, and exhibits antiadrenergic effects by noncompetitive binding to β-adrenergic receptors. Dronedarone hydrochloride is a substrate for and a moderate inhibitor of CYP3A4. | price> |
| R-R-3989 | Midaglizole hydrochloride CAS No.79689-25-1 | Midaglizole hydrochloride (DG5128)/CAS No.79689-25-1 is a preferential α2-adrenoceptor antagonist. Midaglizole hydrochloride (DG5128) exhibits 7.4 times higher affinity (pKi=6.28) toward α2-adrenoceptor than α1-adrenoceptor. | price> |
| R-C-2290 | NSC 207895 CAS:58131-57-0 | NSC207895 is a cell-permeable benzofuroxan compound that downregulates the p53 negative regulator MDMX protein level in MCF-7,LNCaP,and A549 cells(1 to 10µM for 16 to 24h)by suppressesing MDMX promoter transcription activity(IC50=2.5µM in HT1080 cells),leading to enhanced p53 stabilization and activation. | price> |
| R-R-3990 | Tranilast CAS No.53902-12-8 | Tranilast (MK-341)/CAS No.53902-12-8 acts as an anti-atopic agent. Tranilast suppresses production of prostaglandin D2 (PGD2, IC50= 0.1 mM). Tranilast sodium exhibits anti-inflammatory and immunomodulatory effects. Tranilast sodium antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells. | price> |
| R-C-2291 | CC-885 CAS:1010100-07-8 | CC-885 is a potent Cereblon Modulator with potent antitumor activity mediated through the degradation of GSPT1.was demonstrated to mediate antitumor effects through the recruitment and degradation of G1 to S phase transition 1 protein (GSPT1).GSPT1(also named eRF3a)is a translation termination factor that binds eukaryotic translation termination factor 1(eFR1)to mediate stop codon recognition and nascent protein release from the ribosome. | price> |
| R-R-3991 | Valsartan CAS No.137862-53-4 | Valsartan (CGP 48933)/CAS No.137862-53-4 is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research. | price> |
| R-C-2292 | Mezigdomide (CC-92480) CAS:2259648-80-9 | CC-92480,a cereblon E3 ubiquitin ligase modulating drug(CELMoD),acts as a molecular glue.CC-92480 shows high affinity to cereblon,resulting in potent antimyeloma activity. | price> |
| R-R-3992 | Talfirastide CAS No.51833-78-4 | Angiotensin 1-7 (Ang-(1-7))/CAS No.51833-78-4 is an endogenous heptapeptide from the renin-angiotensin system (RAS) with a cardioprotective role due to its anti-inflammatory and anti-fibrotic activities in cardiac cells. Angiotensin 1-7 inhibits purified canine ACE activity (IC50=0.65 μM). Angiotensin 1-7 acts as a local synergistic modulator of kinin-induced vasodilation by inhibiting ACE and releasing nitric oxide. Angiotensin 1-7 blocks Ang II-induced smooth muscle cell proliferation and hypertrophy and shows antiangiogenic and growth-inhibitory effects on the endothelium. Angiotensin 1-7 shows anti-inflammatory activity . | price> |
| R-C-2293 | Thalidomide-O-COOH (Cereblon ligand 3) CAS:1061605-21-7 | Thalidomide-O-COOH(Cereblon ligand 3,E3 ligase Ligand 3),a Thalidomide-based Cereblon(CRBN)ligand,is used in the recruitment of CRBN protein. Thalidomide-O-COOH(Cereblon ligand 3)can be connected to the ligand for protein by a linker to form PROTACs(Proteolysis Targeting Chimera). | price> |
| R-R-3993 | Buloxibutid CAS No.477775-14-7 | Buloxibutid (AT2 receptor agonist C21)/CAS No.477775-14-7 is a agentlike selective angiotensin II AT2 receptor agonist with Ki values of 0.4 nM and >10 μM for the AT2 receptor and AT1 receptor, respectively. | price> |
| R-C-2294 | NAcM-OPT CAS:2089293-61-6 | NAcM-OPT is an orally bioavailable cullin neddylation 1(DCN1)inhibitor,which potently inhibits the DCN1-UBE2M interaction. | price> |
| R-R-3994 | Irbesartan CAS No.138402-11-6 | Irbesartan (SR-47436)/CAS No.138402-11-6 is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease. | price> |
| R-C-2295 | NSC697923 CAS:343351-67-7 | NSC697923 is a potent UBE2N(ubiquitin-conjugating enzyme E2 N,Ubc13) inhibitor. NSC697923 induces neuroblastoma(NB)cell death via promoting nuclear importation of p53 in p53 wild-type NB cells.NSC697923 also induces cell death in p53 mutant NB cells by activation of JNK-mediated apoptotic pathway.NSC697923 inhibits DNA damage and NF-κB signaling.Antitumor activity. | price> |
| R-R-3995 | Olmesartan CAS No.144689-24-7 | Olmesartan (RNH-6270)/CAS No.144689-24-7 is an angiotensin II receptor (AT1R) antagonist used to treat high blood pressure. | price> |
| R-C-2296 | Levetiracetam (UCB-L059) CAS:102767-28-2 | Levetiracetam, an antiepileptic agent,binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis.Levetiracetam modulates HDAC levels ultimately silencing MGMT,thus increasing Temozolomide effectiveness.A chemosensitizer agent. | price> |
| R-R-3996 | Olodanrigan CAS No.1316755-16-4 | Olodanrigan (EMA401)/CAS No.1316755-16-4 is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. It is under development as a neuropathic pain therapeutic agent. Olodanrigan (EMA401) analgesic action appears to involve inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons. | price> |
| R-C-2297 | Cilnidipine (FRC-8653) CAS:132203-70-4 | Cilnidipine(FRC-8653)is a calcium channel blocker.Cilnidipine is the novel calcium antagonist accompanied with L-type and N-type calcium channel blocking function.It was approved in 1995.Compared with other calcium antagonists,cilnidipine can act on the N-type calcium channel that existing sympathetic nerve end besides acting on L-type calcium channel that similar to most of the calcium antagonists. | price> |
| R-R-3997 | PD 123319 ditrifluoroacetate CAS No.136676-91-0 | PD 123319 (ditrifluoroacetate)/CAS No.136676-91-0 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


